Meeting
2013 ASCO Annual Meeting
Massively parallel sequencing (MPS) of circulating DNA in patients with metastatic colorectal cancer (mCRC): Prognostic significance and early changes during chemotherapy (CT).
Authors
Jeanne Tie
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
Jeanne Tie , Isaac Kinde , Hui-Li Wong , Joseph James McKendrick , Peter Gibbs , Madhu Sudan Singh , Christos Stelios Karapetis , Jayesh Desai , Ben Tran , Justin Kelvin Roebert , Kenneth W. Kinzler , Bert Vogelstein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Genomic and Epigenomic Biomarkers
Citation
J Clin Oncol 31, 2013 (suppl; abstr 11015)
DOI
10.1200/jco.2013.31.15_suppl.11015
Abstract #
11015
Poster Bd #
4
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Tumor genomics and sidedness to predict outcomes in metastatic colorectal cancer (mCRC).
First Author: Patrick M Boland
Poster
2017 ASCO Annual Meeting
Profiling circulating tumor (ct)DNA mutations after panitumumab treatment in patients with refractory metastatic colorectal cancer (mCRC) from the phase III ASPECCT study.
First Author: Michael Boedigheimer
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2014 ASCO Annual Meeting
Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.
First Author: Daniela Adua